The need to protect cancer nurses from exposure to hazardous drugs
Freelance medical writer Christine Clark (email@example.com) reports on an online meeting held in May 2022 as part of a series on the risks of exposure to hazardous drugs for nurses working in oncology
On 5 May 2022 Aesculap Academia (the educational arm of B. Braun Medical) held a third webinar to discuss the results of research into the use of closed system transfer devices and the wider issues concerning the risks for nurses of occupational exposure to hazardous drugs. The earlier webinars in this series, held in November 2020 and April 2021, were reported in previous BJN oncology supplements (Clark, 2021a; Clark, 2021b).
An audience of 162 participants from around the world attended an interactive webinar to learn more about cancer nurses' risks of exposure to hazardous drugs.
Opening the meeting Co-Chairs Mark Foulkes (President of the UK Oncology Nursing Society (UKONS) and Nurse Consultant and Lead Cancer Nurse, Royal Berkshire NHS Foundation Trust) and Naomi Clatworthy (Acute Oncology Nurse Consultant, Royal Devon University Healthcare NHS Foundation Trust) commented that the previous two meetings had been strong meetings with lots of audience participation.
Register now to continue reading
Thank you for visiting British Journal of Nursing and reading some of our peer-reviewed resources for nurses. To read more, please register today. You’ll enjoy the following great benefits:
Limited access to clinical or professional articles
Unlimited access to the latest news, blogs and video content